Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions to force lower prices.

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

New government inflation data shows the pace of inflation has subsided from pandemic-era highs. Social Security beneficiaries ...

Prior to the law, Medicare paid what the drug companies ... order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits over what the ...